CapsoVision vs Nuwellis
CV and NUWE side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CV and NUWE compare
CapsoVision is the larger company, worth 115 times as much as Nuwellis ($314M against $2.7M).
Nuwellis grew revenue faster over the last twelve months (10.3% versus 6.4% for CapsoVision).
Nuwellis keeps more of each dollar of sales as profit, with a net margin of −153% compared with −210% at CapsoVision.
Nuwellis scores higher on the StockData Score (10 against 6 for CapsoVision), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CV | NUWE |
|---|---|---|
| Size and price | ||
| Market cap | $314M | $2.7M |
| Share price | $6.27 | $5.03 |
| Change, 1 year | 15.2% | −99.4% |
| Change, 5 years | – | −100.0% |
| Beta (5Y) | −1.09 | – |
| Employees | 99 | 24 |
| StockData Score | ||
| Total score | 6 | 10 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 6 (better) | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 22.5× | 0.3× (better) |
| P/B | 11.9× | 0.3× (better) |
| FCF yield | −9.3% (better) | −452% |
| Fair value | $1.28 | $27.50 |
| Margin of safety | −391% | 81.7% (better) |
| Growth | ||
| Revenue growth (TTM) | 6.4% | 10.3% (better) |
| Revenue growth, 5Y average | – | 2.1% |
| Profitability | ||
| Gross margin | 49.7% | 70.8% (better) |
| Operating margin | −212% | −136% (better) |
| Net margin | −210% | −153% (better) |
| FCF margin | −210% | −137% (better) |
| Return on equity | −125% (better) | −200% |
| Return on invested capital | −99.6% (better) | −816% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 5.07 (better) | 3.99 |
| Altman Z-score | 20.27 (better) | −35.20 |
| Piotroski F-score | 3 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 10.2% | 3.9% |
| Held by insiders | 29.0% | – |
| Insider net buying, 12 months | $21.0M | – |
| Short interest, % of float | 5.5% | – |
Go deeper
- CV stock overview
- CV income statement
- CV valuation and score
- NUWE stock overview
- NUWE income statement
- NUWE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.